These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23267937)
1. [Recurrent breast cancer obtained long-term survival with local treatment(surgery and stereotactic body radiotherapy)and systemic therapy]. Morioka E; Ohno Y; Noguchi M; Nakano Y; Noguchi M; Kosaka T; Takanaka T Gan To Kagaku Ryoho; 2012 Nov; 39(12):1942-4. PubMed ID: 23267937 [TBL] [Abstract][Full Text] [Related]
2. [A case of bilateral multiple primary breast cancer]. Waga E; Sakurai K; Fujisaki S; Maeda T; Nagashima S; Hara Y; Tomita R; Suzuki S; Enomoto K; Amano S Gan To Kagaku Ryoho; 2012 Nov; 39(12):2036-8. PubMed ID: 23267968 [TBL] [Abstract][Full Text] [Related]
3. [Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery]. Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M Gan To Kagaku Ryoho; 2010 Jan; 37(1):115-8. PubMed ID: 20087043 [TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent breast cancer with lung metastasis resection showing four disease-free years under trastuzumab treatment]. Hanada N; Tomiyama N; Hori K; Kusano S; Yoshida Y; Kawata K; Uchino R; Sakashita N Gan To Kagaku Ryoho; 2010 Dec; 37(13):2905-7. PubMed ID: 21160267 [TBL] [Abstract][Full Text] [Related]
5. [The case of a long-surviving patient with breast cancer and brain metastases treated using multidisciplinary therapy]. Nishimura A; Nishi T; Morohashi S; Okano K; Hakamada K Gan To Kagaku Ryoho; 2014 Nov; 41(12):1897-9. PubMed ID: 25731368 [TBL] [Abstract][Full Text] [Related]
6. [Treatment strategy of breast carcinoma in the elderly patient-surgery, hormone therapy, and chemotherapy]. Sakurai K; Fujisaki S; Matsuo S; Ogura M; Enomoto K; Kitajima A; Tani M; Amano S; Shiono M Gan To Kagaku Ryoho; 2009 Nov; 36(12):2105-7. PubMed ID: 20037338 [TBL] [Abstract][Full Text] [Related]
7. [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC]. Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M Gan To Kagaku Ryoho; 2010 Jan; 37(1):111-3. PubMed ID: 20087042 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer in very young women. Liukkonen S; Leidenius M; Saarto T; Sjöström-Mattson J Eur J Surg Oncol; 2011 Dec; 37(12):1030-7. PubMed ID: 21937191 [TBL] [Abstract][Full Text] [Related]
9. [Radiation-induced squamous cell carcinoma of the chest wall seven years after adjuvant radiotherapy following the surgery of breast cancer: a case report]. Yokota T; Roppongi T; Kanno K; Tsutsumi H; Sakamoto I; Fujii T Kyobu Geka; 2000 Dec; 53(13):1133-6. PubMed ID: 11127562 [TBL] [Abstract][Full Text] [Related]
10. [A long-term survival case of local recurrence of breast cancer treated with combined modality therapy]. Katsuta E; Ohkubo T; Someno Y; Saguchi M; Aoyagi H; Takahata T; Hasegawa K; Hamada S; Kaneko J; Maejima S Gan To Kagaku Ryoho; 2010 Nov; 37(12):2760-2. PubMed ID: 21224704 [TBL] [Abstract][Full Text] [Related]
11. [A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock]. Ikeda M; Sonoo H; Oota Y; Fujii S; Shimo T; Miyake A; Seki M; Nomura T; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Kurebayashi J Gan To Kagaku Ryoho; 2010 Dec; 37(13):2917-20. PubMed ID: 21160270 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
14. [A case of locally recurrent breast cancer difficult to differentiate from nodular fasciitis]. Kakimoto M; Nakata T; Imaizumi K; Hirano T; Yamamoto Y; Chikatani K; Hoshino M; Matsuyama T; Motoyama K; Goto H; Yoshimura T; Koshiishi H; Tsuruta K Gan To Kagaku Ryoho; 2014 Nov; 41(12):1881-3. PubMed ID: 25731362 [TBL] [Abstract][Full Text] [Related]
15. [A case of Stage IV non-operated advanced breast cancer with local recurrence thirteen years after initial therapy]. Morimoto Y; Imai S; Matsumoto T; Kunisue M; Kawasaki S; Yamaguchi K; Okabe M; Kawamoto K; Ito T; Ogasawara K Gan To Kagaku Ryoho; 2007 Oct; 34(10):1693-5. PubMed ID: 17940393 [TBL] [Abstract][Full Text] [Related]
16. A 42-year-old woman with breast cancer. Crawford ED Oncology (Williston Park); 2003 May; 17(5):614; discussion 615-20. PubMed ID: 12800791 [TBL] [Abstract][Full Text] [Related]
17. Two cases with long-term disease-free survival after resection and radiotherapy for solitary brain metastasis from breast cancer with extensive nodal metastases. Saisho S; Takashima S; Ohsumi S; Saeki H; Aogi K; Saeki T; Mandai K; Iwata S; Takeda T Breast Cancer; 2005; 12(3):221-5. PubMed ID: 16110293 [TBL] [Abstract][Full Text] [Related]
18. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Panoff JE; Hurley J; Takita C; Reis IM; Zhao W; Sujoy V; Gomez CR; Jorda M; Koniaris L; Wright JL Breast Cancer Res Treat; 2011 Aug; 128(3):899-906. PubMed ID: 21475999 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study. Sanpaolo P; Barbieri V; Genovesi D Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742 [TBL] [Abstract][Full Text] [Related]
20. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]. Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]